Correlation Between Valneva SE and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Karyopharm Therapeutics, you can compare the effects of market volatilities on Valneva SE and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Karyopharm Therapeutics.
Diversification Opportunities for Valneva SE and Karyopharm Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Valneva and Karyopharm is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Valneva SE and Karyopharm Therapeutics
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Karyopharm Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.99 times less risky than Karyopharm Therapeutics. The stock trades about -0.62 of its potential returns per unit of risk. The Karyopharm Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 90.00 in Karyopharm Therapeutics on August 29, 2024 and sell it today you would lose (2.00) from holding Karyopharm Therapeutics or give up 2.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Valneva SE ADR |
| Karyopharm Therapeutics |
Valneva SE and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Karyopharm Therapeutics
The main advantage of trading using opposite Valneva SE and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| Valneva SE vs. Bright Minds Biosciences | Valneva SE vs. HP Inc | Valneva SE vs. Intel | Valneva SE vs. Chevron Corp |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |